- Home
- SPE vs DERM Comparison
SPE vs DERM Comparison
Compare SPE & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPE
- DERM
- Stock Information
- Founded
- SPE 1993
- DERM 2014
- Country
- SPE United States
- DERM United States
- Employees
- SPE N/A
- DERM N/A
- Industry
- SPE Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- SPE Finance
- DERM Health Care
- Exchange
- SPE Nasdaq
- DERM Nasdaq
- Market Cap
- SPE 166.0M
- DERM 190.7M
- IPO Year
- SPE N/A
- DERM 2021
- Fundamental
- Price
- SPE $15.30
- DERM $7.26
- Analyst Decision
- SPE
- DERM Strong Buy
- Analyst Count
- SPE 0
- DERM 3
- Target Price
- SPE N/A
- DERM $12.67
- AVG Volume (30 Days)
- SPE 25.4K
- DERM 94.9K
- Earning Date
- SPE 01-01-0001
- DERM 11-11-2025
- Dividend Yield
- SPE 8.55%
- DERM N/A
- EPS Growth
- SPE N/A
- DERM N/A
- EPS
- SPE N/A
- DERM N/A
- Revenue
- SPE N/A
- DERM $56,397,000.00
- Revenue This Year
- SPE N/A
- DERM $26.16
- Revenue Next Year
- SPE N/A
- DERM $45.27
- P/E Ratio
- SPE N/A
- DERM N/A
- Revenue Growth
- SPE N/A
- DERM N/A
- 52 Week Low
- SPE $10.26
- DERM $3.54
- 52 Week High
- SPE $12.59
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- SPE 37.84
- DERM 50.72
- Support Level
- SPE $15.45
- DERM $6.91
- Resistance Level
- SPE $15.67
- DERM $7.79
- Average True Range (ATR)
- SPE 0.16
- DERM 0.31
- MACD
- SPE -0.02
- DERM 0.03
- Stochastic Oscillator
- SPE 23.49
- DERM 47.79
About SPE Special Opportunities Fund Inc
Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.